Log in to save to my catalogue

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_csuc_recercat_oai_recercat_cat_2072_370046

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment

About this item

Full title

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment

Publisher

Public Library of Science (PLoS)

Journal title

PloS one, 2018-10

Language

English

Formats

Publication information

Publisher

Public Library of Science (PLoS)

More information

Scope and Contents

Contents

Introduction: The therapeutic response to statins has a high interindividual variability with respect to reductions in plasma LDL-cholesterol (c-LDL) and increases in HDL cholesterol (c-HDL). Many studies suggest that there is a relationship between the rs20455 KIF6 gene variant (c.2155T> C, Trp719Arg) and a lower risk of cardiovascular disease in...

Alternative Titles

Full title

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_csuc_recercat_oai_recercat_cat_2072_370046

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_csuc_recercat_oai_recercat_cat_2072_370046

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

How to access this item